Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
50.09 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 144.531 | 156.098 | 126.353 | 92.642 | 73.685 | 86.337 | 65.594 | 72.354 | 66.074 | 67.828 | 53.587 | 50.213 |
| Short Term Investments
| 114.71 | 19.664 | 10.32 | 12.977 | 11.675 | 2.831 | 2.635 | 0.527 | 1.285 | 1.495 | 0 | 0 |
| Cash and Short Term Investments
| 259.241 | 175.762 | 136.673 | 105.619 | 85.36 | 89.168 | 68.229 | 72.881 | 66.074 | 67.828 | 53.587 | 50.213 |
| Net Receivables
| 114.943 | 88.975 | 78.93 | 66.39 | 45.687 | 52.212 | 42.032 | 26.799 | 33.471 | 23.125 | 27.014 | 38.275 |
| Inventory
| 105.833 | 103.584 | 92.807 | 96.831 | 110.501 | 69.322 | 63.609 | 79.754 | 70.665 | 82.332 | 69.916 | 51.378 |
| Other Current Assets
| 9.583 | 7.563 | 7.274 | 6.777 | 9.538 | 5.485 | 9.753 | 3.272 | 4.439 | 3.683 | 5.033 | 3.635 |
| Total Current Assets
| 489.6 | 378.319 | 318.119 | 279.682 | 255.241 | 220.342 | 187.778 | 184.096 | 175.934 | 197.996 | 172.971 | 165.69 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 315.643 | 264.573 | 271.491 | 280.709 | 253.548 | 210.418 | 185.339 | 152.944 | 142.161 | 138.289 | 116.619 | 107.366 |
| Goodwill
| 3.216 | 3.126 | 3.313 | 3.94 | 3.634 | 3.951 | 4.461 | 3.976 | 3.726 | 4.467 | 0.28 | 0.28 |
| Intangible Assets
| 610.079 | 34.172 | 35.557 | 36.675 | 37.519 | 38.316 | 40.679 | 46.331 | 36.175 | 38.098 | 39.883 | 42.074 |
| Goodwill and Intangible Assets
| 613.295 | 37.298 | 38.87 | 40.615 | 41.153 | 42.267 | 45.14 | 50.307 | 39.901 | 42.565 | 40.163 | 42.354 |
| Long Term Investments
| 15.212 | 2.414 | 3.985 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 53.252 | 38.527 | 22.399 | 24.98 | 25.873 | 30.618 | 27.745 | 31.001 | 27.444 | 6.932 | 6.118 | 0.027 |
| Other Non-Current Assets
| 25.91 | 20.856 | 16.665 | 5.25 | 11.156 | 9.918 | 8.663 | 9.39 | 4.696 | 3.588 | 2.877 | 2.04 |
| Total Non-Current Assets
| 1,023.312 | 363.668 | 353.41 | 351.554 | 331.73 | 293.221 | 266.887 | 243.642 | 214.202 | 191.374 | 165.777 | 151.787 |
| Total Assets
| 1,512.912 | 741.987 | 671.529 | 631.236 | 586.971 | 513.563 | 454.665 | 427.738 | 390.136 | 389.37 | 338.748 | 317.477 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 25.438 | 84.242 | 89.545 | 95.504 | 77.051 | 87.418 | 16.629 | 16.196 | 13.872 | 10.161 | 20.38 | 17.663 |
| Short Term Debt
| 4.342 | 6.049 | 5.184 | 15.62 | 10.916 | 18.229 | 6.312 | 5.366 | 10.934 | 7.594 | 22.104 | 22.052 |
| Tax Payables
| 1.609 | 4.571 | 9.081 | 1.077 | 2.042 | 1.187 | 3.325 | 7.705 | 3.076 | 3.123 | 2.847 | 3.032 |
| Deferred Revenue
| 1.609 | 0 | 0 | 0 | 0 | -56.095 | 0 | 0.097 | 0.643 | 14.013 | 0.643 | 0.642 |
| Other Current Liabilities
| 194.018 | 4.571 | 9.081 | 1.077 | 2.042 | 57.282 | 44.251 | 38.958 | 34.506 | 30.827 | 22.275 | 19.718 |
| Total Current Liabilities
| 225.407 | 94.862 | 103.81 | 112.201 | 90.009 | 106.834 | 67.192 | 60.617 | 59.955 | 62.595 | 65.402 | 60.075 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 589.199 | 96.533 | 99.479 | 51.65 | 55.709 | 31.984 | 40.844 | 32.356 | 30.165 | 36.106 | 10.069 | 15.95 |
| Deferred Revenue Non-Current
| 24.035 | 0 | 0 | 0 | 0 | 0 | 0 | 0.097 | 1.339 | 1.982 | 2.625 | 3.332 |
| Deferred Tax Liabilities Non-Current
| 6.066 | 7.369 | 7.065 | 5.45 | 4.292 | 1.446 | 2.24 | 2.3 | 0.497 | 6.337 | 7.154 | 3.188 |
| Other Non-Current Liabilities
| 28.784 | 14.565 | 15.653 | 13.212 | 9.433 | 8.94 | 7.06 | 3.113 | 2.67 | 0.49 | 1.953 | 1.493 |
| Total Non-Current Liabilities
| 648.084 | 118.467 | 122.197 | 70.312 | 69.434 | 42.37 | 50.144 | 37.866 | 34.671 | 44.915 | 21.801 | 23.963 |
| Total Liabilities
| 873.491 | 213.329 | 226.007 | 182.513 | 159.443 | 149.204 | 117.336 | 98.483 | 94.626 | 107.51 | 87.203 | 84.038 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 |
| Retained Earnings
| 409.268 | 271.723 | 180.337 | 117.773 | 116.37 | 67.485 | 76.235 | 70.855 | 60.323 | 63.11 | 73.809 | 61.947 |
| Accumulated Other Comprehensive Income/Loss
| -8.478 | -8.624 | -6.765 | -3.721 | -4.687 | -4.013 | -2.1 | -4.696 | -2.475 | -1.654 | 0 | 0 |
| Other Total Stockholders Equity
| 238.625 | 265.553 | 271.944 | 288.249 | 269.678 | 268.958 | 263.189 | 263.091 | 237.657 | 220.4 | 177.732 | 171.488 |
| Total Shareholders Equity
| 639.421 | 528.658 | 445.522 | 402.306 | 381.366 | 332.435 | 337.329 | 329.255 | 295.51 | 281.86 | 251.545 | 233.439 |
| Total Equity
| 639.421 | 528.658 | 445.522 | 448.723 | 427.528 | 364.359 | 337.329 | 329.255 | 295.51 | 281.86 | 251.545 | 233.439 |
| Total Liabilities & Shareholders Equity
| 1,512.912 | 741.987 | 671.529 | 631.236 | 586.971 | 513.563 | 454.665 | 427.738 | 390.136 | 389.37 | 338.748 | 317.477 |